[Nature Biotechnology] The USD FDA has given the green light to a clinical trial designed to test patient-derived (iPSCs in patients with Parkinson’s disease.
[Endomimetics (GlobeNewswire)] Endomimetics announced the awarding of a $2.8 million Phase II Small Business Innovation Research (SBIR) grant to support research to evaluate the potential of Bionanomatrixâ„¢ to improve performance of flow diverters used in the treatment of brain aneurysms.
[QB3] A QB3-led team uniting researchers from the University of California campuses at Berkeley, San Francisco, and Santa Cruz was awarded a $12 million grant from the California Institute for Regenerative Medicine (CIRM) to investigate the origins of autism using neural organoids.
[Georgia State University] Dr. Chong Hyun Shin, a research assistant professor in the Institute for Biomedical Sciences at Georgia State University, has received a three-year, $600,000 federal grant to study small molecules targeting obesity-linked diabetes.